Vaccine-induced neutralizing antibodies (nAbs) can target the S protein to inhibit virus infection at multiple stages during the virus entry process, being the RBD the major target for nAbs interfering with viral receptor binding [183,184]. Here, PROS1 is linked to viral infectious disease.